Showing results (1-10 of 161) with videos related to
Sort By:
Pageof 17
Clinics in Chest Medicine|November 17, 2019
New Drugs for the Treatment of TuberculosisElisa H Ignatius, Kelly E DooleyJournal of Pharmaceutical and Biomedical Analysis|January 6, 2021
A validated liquid chromatography tandem mass spectrometry assay for the analysis of pretomanid in plasma samples from pulmonary tuberculosis patientsAndisiwe Malo, Tracy Kellermann, Elisa H Ignatius, et al.Antimicrobial Agents and Chemotherapy|November 24, 2020
Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with TuberculosisElisa H Ignatius, Mahmoud Tareq Abdelwahab, Bronwyn Hendricks, et al.American Journal of Respiratory and Critical Care Medicine|December 1, 2022
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week ResultsKelly E Dooley, Bronwyn Hendricks, Nikhil Gupte, et al.Current HIV/AIDS Reports|September 12, 2020
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TBElisa H Ignatius, Susan SwindellsTransactions of the American Clinical and Climatological Association|August 7, 2025
REVOLUTIONIZING TUBERCULOSIS REGIMEN DEVELOPMENTKelly E Dooley, Radojka SavicClinics in Chest Medicine|April 20, 2005
Treatment of latent tuberculosis infection: challenges and prospectsKelly E Dooley, Timothy R SterlingClinical Pharmacology and Therapeutics|August 24, 2018
State-of-the-Art Review of HIV-TB Coinfection in Special PopulationsEthel D Weld, Kelly E DooleyAnnual Review of Medicine|November 8, 2018
The Global Landscape of Tuberculosis TherapeuticsJeffrey A Tornheim, Kelly E DooleyCurrent Opinion in HIV and AIDS|August 7, 2018
Challenges of TB and HIV co-treatment: updates and insightsJeffrey A Tornheim, Kelly E DooleyPageof 17